title: Pharmacologic Management of Pressure-Induced Stromal Keratopathy after LASIK.
abstract: To emphasize the importance of anticipation of pressure-induced stromal keratopathy (PISK) in eyes with a previous history of LASIK.
  
  
  
  A 40-year-old man developed LASIK-related pressure-induced stromal keratopathy after uneventful phacoemulsification (Phaco) and intraocular lens (IOL) implantation in his left eye. With immediate discontinuation of the steroid drops and initiation of antiglaucoma medication, his visual acuity, interface edema, and haze improved rapidly. One year later, during Phaco with IOL implantation in his other eye, with anticipation of a similar LASIK-related pressure-induced stromal keratopathy, a very brief course of soft steroid therapy was given together with antiglaucoma medication. Intraocular pressure elevation was avoided, and no interface edema or haze was observed.
  
  
  
  This case illustrates that the risk for LASIK-related pressure-induced stromal keratopathy may be reduced with appropriate precautions.
authors.affiliation: *MD Department of Ophthalmology, School of Medicine (MU), Erciyes University, Kayseri, Turkey; Department of Ophthalmology, School of Medicine (AMH, EY), Gazi University, Ankara, Turkey; Department of Ophthalmology (SK), Duzici State Hospital, Duzici, Turkey; and Department of Ophthalmology (DK), Viransehir State Hospital, Sanliurfa, Turkey.
authors.forename: Metin
authors.initials: M
authors.lastname: Unlu
authors.forename: Ahmet M
authors.initials: AM
authors.lastname: Hondur
authors.forename: Safak
authors.initials: S
authors.lastname: Korkmaz
authors.forename: Deniz
authors.initials: D
authors.lastname: Kumova
authors.forename: Erdem
authors.initials: E
authors.lastname: Yuksel
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000068599:Brimonidine Tartrate, Timolol Maleate Drug Combination / Q000627:therapeutic use; D015715:Corneal Edema / Q000188:drug therapy* / Q000209:etiology; D003319:Corneal Stroma / Q000187:drug effects* / Q000473:pathology; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D020731:Keratomileusis, Laser In Situ; D019654:Lens Implantation, Intraocular; D008297:Male; D009798:Ocular Hypertension / Q000188:drug therapy* / Q000209:etiology; D018918:Phacoemulsification; D011183:Postoperative Complications; D014792:Visual Acuity
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000959:Antihypertensive Agents; D000068599:Brimonidine Tartrate, Timolol Maleate Drug Combination; D004232:Diuretics; D000086:Acetazolamide